U.S. Markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
60.03+0.53 (+0.89%)
At close: 1:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close59.50
Open59.64
Bid59.80 x 900
Ask59.97 x 3200
Day's Range59.28 - 60.05
52 Week Range57.04 - 85.97
Volume4,921,858
Avg. Volume9,418,068
Market Cap75.249B
Beta (5Y Monthly)0.55
PE Ratio (TTM)59.61
EPS (TTM)1.01
Earnings DateFeb 02, 2021 - Feb 08, 2021
Forward Dividend & Yield2.72 (4.53%)
Ex-Dividend DateDec 14, 2020
1y Target Est73.72
  • Is Gilead Sciences a Great Dividend Stock?
    Motley Fool

    Is Gilead Sciences a Great Dividend Stock?

    When you think about dividend stocks, biotechs probably don't immediately come to mind. Gilead Sciences' (NASDAQ: GILD) dividend program especially stands out. The company arguably offers the best dividend of any biotech.

  • Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?
    Motley Fool

    Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?

    Gilead Sciences (NASDAQ: GILD) started the year strong. As a result, while the rest of the stock market slid, Gilead did just the opposite. To make matters worse, the World Health Organization (WHO) recently advised against using remdesivir as a treatment for COVID-19.

  • Gilead's New CEO Is Going All-In on Acquisitions
    Motley Fool

    Gilead's New CEO Is Going All-In on Acquisitions

    Daniel O'Day has made increasingly larger deals in an effort to improve the company's portfolio of cancer drugs.